Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21‐year‐old patient: A case report and review-Reference-Cited by-同舟云学术

Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21‐year‐old patient: A case report and review

Published:2019-05-07 Issue:6 Volume:7 Page:1171-1177
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Camus Vincent¹^ORCID,Dubois Sydney²,Thiébaut Pierre‐Alain³,Lepretre Stéphane¹,Lenain Pascal¹,Picquenot Jean‐Michel⁴,Veresezan Elena‐Liana⁴,François Arnaud³,Penther Dominique⁵,Bauer Fabrice⁶,Jaccard Arnaud⁷,Jardin Fabrice¹

Affiliation:

1. Inserm U1245 and Department of Hematology Centre Henri Becquerel and Normandie Univ UNIROUEN Rouen France

2. Department of Internal Medicine Charles Nicolle University Hospital Rouen France

3. Department of Pathology Charles Nicolle University Hospital Rouen France

4. Department of Pathology Centre Henri Becquerel Rouen France

5. Department of Genetic Oncology Centre Henri Becquerel Rouen France

6. Department of Cardiology Charles Nicolle University Hospital Rouen France

7. Centre national de référence de l'amylose AL et des autres maladies par dépôt d'immunoglobulines monoclonales hôpital Dupuytren, CHU de Limoges Limoges cedex France

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2165

Reference28 articles.

1. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989;Kyle RA;Blood,1992

2. Amylose AL

3. Guidelines on the diagnosis and investigation of AL amyloidosis

4. Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

5. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation